Truist Financial Increases Tenet Healthcare (NYSE:THC) Price Target to $270.00

Tenet Healthcare (NYSE:THC) had its price objective upped by research analysts at Truist Financial from $240.00 to $270.00 in a research note issued on Tuesday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s target price would indicate a potential upside of 16.31% from the stock’s previous close.

THC has been the subject of a number of other research reports. Barclays upped their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. Raymond James Financial set a $245.00 price objective on shares of Tenet Healthcare in a research note on Wednesday, October 29th. JPMorgan Chase & Co. increased their target price on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Morgan Stanley reissued an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $246.71.

Tenet Healthcare Stock Down 0.9%

THC stock opened at $232.13 on Tuesday. Tenet Healthcare has a one year low of $109.82 and a one year high of $235.77. The stock has a market capitalization of $20.40 billion, a P/E ratio of 14.99, a PEG ratio of 0.98 and a beta of 1.44. The company has a 50 day moving average price of $200.66 and a two-hundred day moving average price of $196.47. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same quarter last year, the firm earned $3.44 earnings per share. The business’s revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, sell-side analysts expect that Tenet Healthcare will post 12.24 EPS for the current year.

Insider Activity

In related news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in THC. NewEdge Advisors LLC increased its stake in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp increased its position in shares of Tenet Healthcare by 299.1% during the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC purchased a new position in Tenet Healthcare in the second quarter valued at about $290,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Tenet Healthcare during the 2nd quarter valued at approximately $2,512,000. Finally, Chicago Partners Investment Group LLC acquired a new position in shares of Tenet Healthcare in the 2nd quarter valued at approximately $273,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.